Does MYCOPHENOLATE MOFETIL Cause Focal segmental glomerulosclerosis? 181 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Focal segmental glomerulosclerosis have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 0.2% of all adverse event reports for MYCOPHENOLATE MOFETIL.
181
Reports of Focal segmental glomerulosclerosis with MYCOPHENOLATE MOFETIL
0.2%
of all MYCOPHENOLATE MOFETIL reports
5
Deaths
59
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From MYCOPHENOLATE MOFETIL?
Of the 181 reports, 5 (2.8%) resulted in death, 59 (32.6%) required hospitalization, and 7 (3.9%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE MOFETIL. However, 181 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
MYCOPHENOLIC ACID (55)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE